Go to industries


Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
deals closed in Healthcare
Explore all our industry-related deals
Go to deals
Probiomed has been acquired by Sanfer
Private Equity | Healthcare

Probiomed has been acquired by Sanfer

The shareholders of Probiomed S.A. de C.V. have sold the company to Laboratorios Sanfer.

Learn more
“During the last 12 years, I have made move UP what it is today, a valued partner in physical fitness for health insurers and employers. Acture shares my vision of physical health. I look forward to developing the concept of total welfare management together with Acture in Germany and the rest of Europe. I want to express my heartfelt gratitude to the Oaklins team, our invaluable partner throughout this process. Their unwavering dedication and strategic guidance played a pivotal role in navigating the complexities of this deal and we sincerely appreciate their substantial operational support. We are confident and ready to embrace a prosperous future as an integral part of the Acture family.”

Jan-Frederik Kolthoff

Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=MX&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Reshaping industries: M&A highlights and strategic vision

QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.

Learn more

Talk to our local advisors

Andrei Lepiavka

Managing Partner
Mexico City, Mexico
Oaklins ZIMMA

Meet our global industry specialists

Antoine Lemaire

Paris, France
Oaklins France

Robert Boersma

Amsterdam, Netherlands
Oaklins Netherlands

Dino Theodorou

Johannesburg, South Africa
Oaklins Grindrod

Stuart Goodman

London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital